Literature DB >> 3683707

[Clinical symptomatology in aneurysm of the ampulla of Galen. Results of a national survey].

J Maheut1, J J Santini, M A Barthez, C Billard.   

Abstract

Results of a national survey of clinical symptomatology revelatrice of an aneurysm of Galen's ampulla are analyzed and compared with documented data. Three large groups can be distinguished as a function of age at diagnosis: the neonatal period: cardiac insufficiency; childhood: macrocrania; adolescence and adult life: various clinical symptoms and signs but fortuitous discovery not exceptional.

Entities:  

Mesh:

Year:  1987        PMID: 3683707

Source DB:  PubMed          Journal:  Neurochirurgie        ISSN: 0028-3770            Impact factor:   1.553


  5 in total

1.  Congestive cardiac manifestations from cerebrocranial arteriovenous shunts. Endovascular management in 30 children.

Authors:  R Garcia-Monaco; D De Victor; C Mann; A Hannedouche; K Terbrugge; P Lasjaunias
Journal:  Childs Nerv Syst       Date:  1991-02       Impact factor: 1.475

2.  Spontaneous regression of a vein of Galen aneurysmal malformation in a pediatric patient: illustrative case.

Authors:  Kevin K Kumar; Linden E Fornoff; Robert L Dodd; Michael P Marks; David S Hong
Journal:  J Neurosurg Case Lessons       Date:  2021-02-22

Review 3.  Cerebral arteriovenous malformations in children. Management of 179 consecutive cases and review of the literature.

Authors:  P Lasjaunias; F Hui; M Zerah; R Garcia-Monaco; V Malherbe; G Rodesch; A Tanaka; H Alvarez
Journal:  Childs Nerv Syst       Date:  1995-02       Impact factor: 1.475

4.  Vein of Galen malformation. Endovascular management of 43 cases.

Authors:  P Lasjaunias; R Garcia-Monaco; G Rodesch; K Ter Brugge; M Zerah; M Tardieu; D de Victor
Journal:  Childs Nerv Syst       Date:  1991-11       Impact factor: 1.475

5.  Vein of Galen aneurysmal malformations. Report of 36 cases managed between 1982 and 1988.

Authors:  P Lasjaunias; G Rodesch; K Terbrugge; P Pruvost; D Devictor; J Comoy; P Landrieu
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.